Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin
Format: Artigo
Langue:Inglês
Publié: BMC 2022-04-01
Collection:Thrombosis Journal
Sujets:
Ticagrelor
Platelet inhibition rate
Thromboelastography
Acute coronary syndrome
Accès en ligne:https://doi.org/10.1186/s12959-022-00380-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires